论文部分内容阅读
目的了解输血前患者肝炎的感染情况,探讨医源性肝炎传染风险,避免可能发生的医疗纠纷。方法对5863例输血前患者采用ELISA方法检测HBsAg、HBsAb、HBeAg、HBeAb、HBcAb、抗-HCV;采用速率法检测ALT。结果患者血液检测结果异常的总阳性率为23.6%,其中HBsAg阳性831人(阳性率14.2%)、
Objective To understand the infection status of hepatitis before transfusion, explore the risk of iatrogenic hepatitis infection and avoid possible medical disputes. Methods 5863 pretransfusion patients were tested for HBsAg, HBsAb, HBeAg, HBeAb, HBcAb and anti-HCV by ELISA. ALT was detected by the rate method. Results The total positive rate of patients with abnormal blood test results was 23.6%, of which 831 were positive for HBsAg (positive rate was 14.2%),